Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexentis Technologies FCF Margin % Historical Data
* Premium members only.
The historical data trend for Nexentis Technologies's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:80W0 vs PUBC, ENFY, GNVR: FCF Margin % Comparison
For the Agricultural Inputs subindustry, Nexentis Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexentis Technologies FCF Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nexentis Technologies's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nexentis Technologies's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexentis Technologies (STU:80W0) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nexentis Technologies and its competitors. According to the industry distribution chart, Nexentis Technologies ranks #1 out of 248 companies in the Agriculture industry, placing it in the top 0.40000000000001%.
Is Nexentis Technologies' FCF Margin % too high?
Nexentis Technologies' current FCF Margin % is 0.00%. Based on the distribution chart, Nexentis Technologies ranks #1 out of 248 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Nexentis Technologies has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Nexentis Technologies' FCF Margin % compare to PUBC and ENFY?
According to the Agriculture industry distribution chart, Nexentis Technologies ranks #1 out of 248 companies for FCF Margin %. This places Nexentis Technologies in the top 0% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 0.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for an Agriculture company?
The median FCF Margin % among Agriculture companies is 0.58, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nexentis Technologies and its competitors. For the Agriculture industry, the median FCF Margin % is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexentis Technologies's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexentis Technologies stock overvalued right now?
Nexentis Technologies (STU:80W0) has a current FCF Margin % of 0.00%. The stock's GF Value™ is €1,600.26, compared to a current price of €890.09 — trading 44.4% below its estimated fair value. The current FCF Margin % is 0.00%. Nexentis Technologies' overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Nexentis Technologies (STU:80W0), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexentis Technologies (STU:80W0) Overvalued in 2026?
Based on GuruFocus' analysis, Nexentis Technologies stock appears to be undervalued.
The current stock price of €890.09 is trading 44.4% below its estimated GF Value™ of €1,600.26.
Key valuation signals for STU:80W0:
FCF Margin %: 0.00%
GF Value™: €1,600.26 vs. price of €890.09 (44.4% below fair value)
No single metric tells the full story. See the STU:80W0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
44GF Score
Get the complete analysis for STU:80W0
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:80W0 has been successfully added to your 
